MX9707683A - Combination compositions containing benazepril or benazeprilat and valsartan. - Google Patents

Combination compositions containing benazepril or benazeprilat and valsartan.

Info

Publication number
MX9707683A
MX9707683A MX9707683A MX9707683A MX9707683A MX 9707683 A MX9707683 A MX 9707683A MX 9707683 A MX9707683 A MX 9707683A MX 9707683 A MX9707683 A MX 9707683A MX 9707683 A MX9707683 A MX 9707683A
Authority
MX
Mexico
Prior art keywords
benazeprilat
valsartan
combination compositions
compositions containing
formula
Prior art date
Application number
MX9707683A
Other languages
Spanish (es)
Inventor
Marc De Gasparo
Randy Lee Webb
David Saul Cohen
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX9707683A publication Critical patent/MX9707683A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

The invention relates to pharmaceutical combination compositions for the treatment of hypertension, congestive heart failure and renal failure, comprising (1) the ACE-inhibitor benazepril of formula (I) or benazeprilat of formula (II) or a pharmaceutically acceptable salt thereof, and (2) the AT1-antagonist valsartan of formula (III) or a pharmaceutically acceptable salt thereof, as weel as to methods for the treatment of hypertension, congestive heart failure and renal failure.
MX9707683A 1995-04-07 1996-04-02 Combination compositions containing benazepril or benazeprilat and valsartan. MX9707683A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH101295 1995-04-07
PCT/EP1996/001440 WO1996031234A1 (en) 1995-04-07 1996-04-02 Combination compositions containing benazepril or benazeprilat and valsartan

Publications (1)

Publication Number Publication Date
MX9707683A true MX9707683A (en) 1997-12-31

Family

ID=4200393

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9707683A MX9707683A (en) 1995-04-07 1996-04-02 Combination compositions containing benazepril or benazeprilat and valsartan.

Country Status (15)

Country Link
EP (1) EP0820302A1 (en)
JP (1) JPH11503139A (en)
KR (1) KR19980703647A (en)
CN (1) CN1181019A (en)
AU (1) AU5399096A (en)
BR (1) BR9604818A (en)
CA (1) CA2214143A1 (en)
CZ (1) CZ313897A3 (en)
HU (1) HUP9801593A2 (en)
MX (1) MX9707683A (en)
NO (1) NO974400L (en)
PL (1) PL322529A1 (en)
SK (1) SK133897A3 (en)
TR (1) TR199701121T1 (en)
WO (1) WO1996031234A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11508894A (en) * 1995-06-30 1999-08-03 メルク エンド カンパニー インコーポレーテッド Method for treating renal disease using ACE inhibitor and All antagonist
CN101011390A (en) 1999-01-26 2007-08-08 诺瓦提斯公司 Use of angiotensin II receptor antagonists for treating acute myocardial infarction
RU2298418C2 (en) * 2000-04-12 2007-05-10 Новартис Аг Combination of at least two compounds chosen from groups at1-receptor antagonists or inhibitors of ace (angiotensin-converting enzyme) or inhibitors of hmg-coa-reductase (beta-hydroxy-beta-methylglutaryl-coenzyme-a-reductase)
DK1313714T3 (en) 2000-07-19 2008-12-15 Novartis Ag Valsartan salts
JP2004520268A (en) * 2000-08-22 2004-07-08 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト Pharmaceutical composition containing an angiotensin II antagonist and an angiotensin I converting enzyme inhibitor
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination
WO2002049645A1 (en) * 2000-12-18 2002-06-27 Novartis Ag Therapeutic combination of amlodipine and benazepril
US6869970B2 (en) * 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
CN100377744C (en) * 2002-07-05 2008-04-02 安徽省生物医学研究所 Compound medicine for predicting ACEI pressure reducing medicine effect
EP1578360A4 (en) * 2002-08-28 2009-10-21 Curis Inc Conjoint administration of morphogens and ace inhibitors in treatment of chronic renal failure
EP1908469A1 (en) * 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
CN101869710A (en) * 2009-04-24 2010-10-27 北京奥萨医药研究中心有限公司 Antihypertensive medical composite
SG176585A1 (en) 2009-05-20 2012-01-30 Boehringer Ingelheim Vetmed Pharmaceutical oral telmisartan solution
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
CN113144204A (en) * 2014-01-31 2021-07-23 詹森药业有限公司 Method for treating and preventing renal and fatty liver diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2081564C (en) * 1990-05-11 1998-02-03 Anthony Andrea Fossa Synergistic therapeutic compositions and methods
EP0629408A1 (en) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination of angiotensin converting enzyme inhibitors and AII antagonists

Also Published As

Publication number Publication date
JPH11503139A (en) 1999-03-23
SK133897A3 (en) 1998-02-04
PL322529A1 (en) 1998-02-02
EP0820302A1 (en) 1998-01-28
BR9604818A (en) 1998-06-09
CN1181019A (en) 1998-05-06
NO974400D0 (en) 1997-09-23
WO1996031234A1 (en) 1996-10-10
CZ313897A3 (en) 1998-01-14
TR199701121T1 (en) 1998-03-21
KR19980703647A (en) 1998-12-05
NO974400L (en) 1997-09-23
AU5399096A (en) 1996-10-23
CA2214143A1 (en) 1996-10-10
HUP9801593A2 (en) 1999-01-28

Similar Documents

Publication Publication Date Title
MX9707683A (en) Combination compositions containing benazepril or benazeprilat and valsartan.
GEP20053470B (en) N-Heteroaryl-Pyridinesulfonamide Derivatives and Their Use as Endothelin Antagonists
IL133623A0 (en) Antithrombotic agents
IL133627A0 (en) Antithrombotic agents
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
GB9914486D0 (en) Medicaments
UA49869C2 (en) NAPHTHYL-SUBSTITUTED BENZIMIDAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, METHOD FOR TREATMENT (VARIANTS), METHOD FOR INHIBITING HUMAN FACTOR Xa OR IIa
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
BG106340A (en) Substituted oxoazaheterocyclyl compounds
BG104177A (en) Amlodipin- and atorvastatin-containing therapeutical combinations
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
MY133473A (en) Haterocyclic glycyl beta-alanine derivatives.
HUP9900773A3 (en) Use of carbazole derivatives for producing pharmaceutical compositions suitable for the treatment of congestive heart failure
MXPA02003977A (en) INHIBITORS OF agr;L.
BG103947A (en) Derivatives of 9-oxymerythromycin
IL112622A0 (en) Camptothecin derivatives, their preparation and pharmaceutical compositions containing them
ZA953537B (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
RO118870B1 (en) (e)-alpha-[2-n-buthyl-1-[(4-carboxyphenyl)methyl]-1h-imidazole-5-yl]methylene -2-thiophenepropionic acid monomethanesulphonate, processes for its production and pharmaceutical compositions.
WO1992019211A3 (en) Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
AU4080097A (en) Piperazino derivatives as neurokinin antagonists
WO1999026932A8 (en) By amidino group substituted heterocyclic derivatives and their use as anticoagulants
DE69530123D1 (en) Plättchenaggregationsinhibitoren
CA2219359A1 (en) Hydantoin derivatives as intermediates for pharmaceutical active compounds
MX9708416A (en) Piperazino derivatives as neurokinin antagonists.
EP1019047A4 (en) Antithrombotic agents